Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NIH transition announcement about terminology updates and related FAQs was removed from the top of the page; the study-record error page remains otherwise unchanged.
    Difference
    1%
    Check dated 2026-11-08T12:20:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:09:32.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-25T13:00:41.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains an error page, with the footer revision updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:55:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:06:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record content. This prevents users from accessing the trial details and related information on that page.
    Difference
    21%
    Check dated 2026-09-20T20:26:18.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.